What is the best antibiotic for acute bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Acute Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults, providing superior coverage against β-lactamase-producing organisms and drug-resistant Streptococcus pneumoniae compared to amoxicillin alone. 1, 2

First-Line Treatment Selection

For adults with mild disease and no recent antibiotic use (past 4-6 weeks):

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily remains the optimal choice with 90-91% predicted clinical efficacy and 97-99% bacteriologic efficacy 1, 2
  • Plain amoxicillin 500 mg twice daily is acceptable only for uncomplicated cases without recent antibiotic exposure, but has lower efficacy (87-88% clinical, 91-92% bacteriologic) 1
  • A recent 2021 RCT found no additional benefit from high-dose amoxicillin-clavulanate (1750 mg amoxicillin component) compared to standard dosing, with similar efficacy but increased diarrhea risk 3

For adults with recent antibiotic use (past 4-6 weeks) or moderate-to-severe disease:

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily is mandatory as first-line therapy 1, 2
  • Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily) provide 92% clinical efficacy and 100% bacteriologic efficacy, but should be reserved for treatment failures or penicillin allergy 1, 2, 4

Treatment Duration

  • Standard duration is 5-10 days, with most guidelines recommending treatment until symptom-free for 7 days (typically 10-14 days total) 2, 5
  • Shorter 5-7 day courses have comparable efficacy with fewer side effects 2
  • Levofloxacin 750 mg once daily for 5 days is FDA-approved and non-inferior to 10-day regimens 4

Penicillin-Allergic Patients

For non-severe penicillin allergy (e.g., rash):

  • Second-generation cephalosporins: cefuroxime axetil 250-500 mg twice daily 1, 2
  • Third-generation cephalosporins: cefpodoxime proxetil 200-400 mg twice daily or cefdinir 300 mg twice daily 1, 2
  • The risk of cross-reactivity with second- and third-generation cephalosporins in penicillin-allergic patients is negligible 2

For severe Type I hypersensitivity (anaphylaxis):

  • Respiratory fluoroquinolones are the only appropriate option: levofloxacin 500 mg once daily for 10 days or moxifloxacin 400 mg once daily for 10 days 1, 2, 5
  • Do NOT use azithromycin or other macrolides due to 20-25% resistance rates against S. pneumoniae and H. influenzae 1, 2
  • TMP-SMX and doxycycline have limited effectiveness (81-83% clinical efficacy) with 20-25% bacterial failure rates 1

Treatment Failure Protocol

If no improvement after 72 hours (pediatrics) or 3-5 days (adults):

  • Switch to respiratory fluoroquinolones (levofloxacin or moxifloxacin) if initially treated with amoxicillin-clavulanate 1, 2
  • Consider ceftriaxone 1-2 grams IV once daily if oral therapy fails 1
  • Reevaluate the diagnosis—obtain CT scan, fiberoptic endoscopy, or sinus aspiration for culture 1

Pediatric Dosing (Ages 1-18 Years)

Standard therapy (no risk factors):

  • Amoxicillin 45 mg/kg/day divided twice daily 1, 5, 6

High-risk patients (age <2 years, daycare attendance, recent antibiotic use within 4 weeks, high local prevalence of resistant S. pneumoniae):

  • High-dose amoxicillin-clavulanate 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses (maximum 2 g every 12 hours) 1, 5, 6

Penicillin-allergic children:

  • Cefpodoxime proxetil 8 mg/kg/day in 2 doses 1, 2
  • Cefdinir or cefuroxime axetil are alternatives 1
  • Ceftriaxone 50 mg/kg IM/IV once daily for children unable to tolerate oral medication 2

Reassess at 72 hours—if worsening or no improvement, switch to high-dose amoxicillin-clavulanate or ceftriaxone 1, 6

Adjunctive Therapies

  • Intranasal corticosteroids reduce mucosal inflammation and may decrease antibiotic use 1, 2, 5
  • Short-term oral corticosteroids (e.g., prednisone for 5 days) are reasonable for marked mucosal edema or treatment failure 2
  • Saline nasal irrigation improves mucociliary clearance 5
  • Analgesics (acetaminophen, NSAIDs) for pain control 2

Critical Pitfalls to Avoid

  • Never use azithromycin or clarithromycin as first-line therapy due to high resistance rates (20-25% bacterial failure) 1, 2
  • Reserve fluoroquinolones for treatment failures or severe penicillin allergy to prevent resistance development 1, 2
  • Do not use doxycycline or TMP-SMX unless absolutely necessary due to limited effectiveness (81-83% clinical efficacy) 1
  • Ensure adequate treatment duration (minimum 5 days, typically 7-10 days) to prevent relapse 2, 5
  • Reassess at 72 hours (pediatrics) or 3-5 days (adults) if no improvement to avoid treatment failure 1, 6

Special Anatomic Considerations

For frontal, ethmoidal, or sphenoidal sinusitis (not maxillary):

  • Respiratory fluoroquinolones (levofloxacin or moxifloxacin) are preferred due to potential for serious complications 1, 2
  • These locations require more aggressive initial therapy compared to uncomplicated maxillary sinusitis 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Acute Bacterial Sinusitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.